COVID-19 Impact on Launch Performance

How has COVID-19 impacted launch performance and timing?

Pharmaceutical leaders are facing some of the toughest challenges of their careers when it comes to launching in the midst of COVID-19. With so much at stake and so much uncertainty, companies are looking for fact-based insights to power their decision-making.

Trinity has done an in-depth evaluation of the impact of COVID-19 on launch performance and timing. We have compared forecasted/expected revenue to actual revenue for products that launched within six months of COVID-19. We have also explored products that received approval during COVID-19 but have had to delay launch.

Join us to hear the findings and get answers that will help you predict the impact on your product launches.

Key Topics

• Case studies of recently launched products that experienced significant challenges and successes through COVID-19
• Insights into the types of product and market factors that contributed to these successes and challenges
• A review of companies that delayed product launches and the impact of COVID-19 on expected FDA approval dates

Fill out the fields below to view “Webinar: COVID-19 Impact on Launch Performance.”

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.